1887

Emerging infections 10

Editors: W. Michael Scheld1, James M. Hughes2, Richard J. Whitley3
VIEW AFFILIATIONS HIDE AFFILIATIONS
Affiliations: 1: Department of Infectious Diseases, University of Virginia Health System, Charlottesville, VA; 2: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA; 3: Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL
Content Type: Monograph
Format: Hardcover
Publication Year: 2016

Category: Bacterial Pathogenesis; Clinical Microbiology

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this book:
Digital (?) Non-Member $150.00
Become an ASM member! Or renew your membership today! Discount on books and more for members at Contributing level and above. Sign in/Register first and then select a membership

Incidences such as the 2014 Ebola epidemic in West Africa and the 2015 appearance of Zika in Brazil provide dramatic evidence of the continued ability of microbes to emerge, spread, adapt, and threaten global health. The challenge facing infectious disease specialists and public health professionals is to improve and find new diagnostic, therapeutic, and prevention strategies.

The editors of the 10th installment of the series have compiled the perspectives of leading infectious disease experts into 22 chapters that provide important updates on a broad range of emerging and reemerging bacterial, viral, parasitic, and fungal infectious diseases in the United States and globally. In addition to focusing on MERS, Ebola virus disease, chikungunya, and Zika virus disease, explores the global threat of antimicrobial resistance in reviews on carbapenem-resistant , multiply-resistant gonococcal infections, non-typhoidal infections, and artemisinin-resistant Plasmodium falciparum malaria. Topics include both recently- and long-recognized diseases that pose challenges for the clinical, laboratory, research, public health, and animal health communities.

presents new and emerging strategies to prevent, control, and eradicate infectious diseases and guides readers to the primary literature where they can explore individual topics in greater depth. This book is a valuable reference for professionals in microbiology, epidemiology, public health, and clinical and veterinary medicine.

—Martin J. Blaser, M.D., Director, Human Microbiome Program, New York Universitym, Author of Missing Microbes

—David C. Hooper, MD, Professor of Medicine, Harvard Medical School; Chief, Infection Control Unit and Associate Chief, Division of Infectious Diseases, Massachusetts General Hospital

Loading full text...

Full text loading...

/deliver/fulltext/10.1128/9781555819453/cont01.html?itemId=/content/book/10.1128/9781555819453.cont01&mimeType=html&fmt=ahah

Click Here to Take a Look

image of Emerging infections 10

 Scheld Review

10 January 2017

Description

The 10th volume of this series, which originated in 1998, remains highly pertinent and informative as emerging and re-emerging infectious diseases become ever more important. Written by 49 well-qualified authors (including over a dozen from outside the U.S.) from major academic institutions as well as the CDC, FDA, NIH, and WHO, the 22 chapters examine emerging pathogens MERS, Enterovirus D68, Chikungunya, Zika, carbapenem-resistant Enterobacteriaceae (CRE), antibiotic-resistant gonorrhea, etc. Three chapters are dedicated to Ebola due to its recent impact and general interest.

Purpose

The three well-known editors seek to update readers on a wide-ranging list of prominent emerging viral, bacterial, and fungal pathogens as well as a few less well-known or more esoteric pathogens such as B. holmesii, Cronobacter spp., tick-borne bacterial pathogens, and amphibian fungal diseases. In addition, several chapters deal with more mechanistic concerns such as punctuated evolution in the pathogenicity of influenza, fungal contamination of steroid injections, and challenges in preventing the re-emergence of measles.

Audience

Students, teachers, clinicians, laboratorians, and investigators in the disciplines of microbiology, infectious diseases, and public health will find value in the concise, well-written, and adequately referenced chapters.

Features

The foreword and preface do a nice job of setting the scene. The first three chapters on Ebola are organized into West African experience, lessons from Ebola in preparing for serious communicable diseases in the United States, and Ebola therapeutics. Although each chapter is excellent on its own, there is substantial redundancy when read together. To better hold the reader's attention, the authors of almost all of the chapters (exceptions are non-typhoidal salmonella and Zika) offer appropriate graphics, charts, and tables. The chapters on MERS, measles, Enterovirus D68, and C. difficile are concise yet comprehensive reviews. The scope of the chapter on CRE concentrates on epidemiology and laboratory detection, but does not address other clinical issues.

Assessment

Global forces such as population growth, climate change, world travel, and trade will continue to influence the emergence and transmission of infectious diseases. This volume nicely summarizes information on a variety of pathogens and serves as a great reminder of the importance of preparedness and public health on a national and global scale.

Weighted Numerical Score: 90 - 4 Stars!

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error